Skeletal muscle mass loss and dose‐limiting toxicities in metastatic colorectal cancer patients
出版年份 2019 全文链接
标题
Skeletal muscle mass loss and dose‐limiting toxicities in metastatic colorectal cancer patients
作者
关键词
-
出版物
Journal of Cachexia Sarcopenia and Muscle
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-05-16
DOI
10.1002/jcsm.12436
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The evolution of body composition in oncology-epidemiology, clinical trials, and the future of patient care: facts and numbers
- (2019) Justin C. Brown et al. Journal of Cachexia Sarcopenia and Muscle
- A randomized trial of adjunct testosterone for cancer-related muscle loss in men and women
- (2018) Traver J. Wright et al. Journal of Cachexia Sarcopenia and Muscle
- LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial
- (2018) Talia Golan et al. Journal of Cachexia Sarcopenia and Muscle
- Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients
- (2018) Sophie A. Kurk et al. Journal of Cachexia Sarcopenia and Muscle
- MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study
- (2017) Tamas Hickish et al. LANCET ONCOLOGY
- Ethical guidelines for publishing in the journal of cachexia, sarcopenia and muscle: update 2017
- (2017) Stephan von Haehling et al. Journal of Cachexia Sarcopenia and Muscle
- Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer
- (2016) Susanne Blauwhoff-Buskermolen et al. JOURNAL OF CLINICAL ONCOLOGY
- Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials
- (2016) Jennifer S Temel et al. LANCET ONCOLOGY
- Can body composition be used to optimize the dose of platinum chemotherapy in lung cancer? A feasibility study
- (2016) Vincent Crosby et al. SUPPORTIVE CARE IN CANCER
- Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non-small cell lung cancer or colorectal cancer: a randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial)
- (2016) Andrew J. Stewart Coats et al. Journal of Cachexia Sarcopenia and Muscle
- Lean body mass as an independent determinant of dose-limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens
- (2016) Raafi Ali et al. Cancer Medicine
- A review of relative dose intensity and survival in patients with metastatic solid tumors
- (2015) Laura J. Havrilesky et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The role of body composition evaluation by computerized tomography in determining colorectal cancer treatment outcomes: A systematic review
- (2015) G. Malietzis et al. EJSO
- Negative Impact of Skeletal Muscle Loss after Systemic Chemotherapy in Patients with Unresectable Colorectal Cancer
- (2015) Yuji Miyamoto et al. PLoS One
- Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: Randomised trial
- (2014) Karla Sánchez-Lara et al. CLINICAL NUTRITION
- Sarcopenia Is Linked to Treatment Toxicity in Patients With Metastatic Colorectal Cancer
- (2014) Maximilien Barret et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?
- (2013) Carla M Prado et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Assessment of Nutritional Status in Cancer – The Relationship Between Body Composition and Pharmacokinetics
- (2013) Carla Prado et al. Anti-Cancer Agents in Medicinal Chemistry
- Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
- (2013) Lisa Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial
- (2013) Adrian S Dobs et al. LANCET ONCOLOGY
- Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer
- (2013) Sami Antoun et al. Current Opinion in Supportive and Palliative Care
- Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: A randomized double-blind placebo controlled trial
- (2012) Zohreh Ghoreishi et al. BMC CANCER
- Overestimation of risk ratios by odds ratios in trials and cohort studies: alternatives to logistic regression
- (2011) M. J. Knol et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- Dose-Dense Chemotherapy in Nonmetastatic Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials
- (2010) L. Bonilla et al. JNCI-Journal of the National Cancer Institute
- A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care
- (2008) Marina Mourtzakis et al. Applied Physiology Nutrition and Metabolism
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
- (2008) Carla MM Prado et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now